TP-472N,≥98% (HPLC)

别名:1-[8-[2-(环丙基甲氧基)苯基]吡咯并[1,2-a]嘧啶-6-基]-乙酮;1-[8-[2-(Cyclopropylmethoxy)phenyl]pyrrolo[1,2-a]pyrimidin-6-yl]-ethanone;TP472N

Empirical Formula (Hill Notation): C19H18N2O2 CAS号: 2080306-24-5 分子量: 306.36 MDL编号: MFCD30720894
制造商品牌: 西格玛 Sigma-Aldrich
货号(SKU): SML1933
CAS号: 2080306-24-5
MDL号: MFCD30720894
签订合同 √ 正规发票 √ 技术支持 √ 质量保障 √ 全程可追溯 √
¥2,340.20

说明

生化/生理作用

TP-472N is a negative control probe for TP-472. TP-472 is a selective probe for bromodomain-containing proteins BRD9 and BRD7. The BRD9/7 probe was developed out of a collaborative effort by Takeda and the SGC, and is of a different chemotype from BRD9/7 probes previously available. TP-472 has a KD value of 33nM for BRD9 and 340nM for BRD7 by ITC, is >30 fold selective for BRD9 over all other bromodomain family members except BRD7, and is suitable for in vivo applications. The negative control TP-472N is inactive against other bromodomains (>20μM against BRD9). For full characterization details of TP-472 and TP-472N, please visit the TP-472 probe summary on the Structural Genomics Consortium (SGC) website.

TP-472, the active BRD9/7 probe, is available from Sigma. To learn more about and purchase TP-472, click here.
To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc
 

特点和优势

TP-472N is an epigenetic chemical probe available through a partnership with the Structural Genomics Consortium (SGC). To learn more and view other SGC epigenetic probes, visit sigma.com/SGC.
This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
 
 

属性

质量水平

100

测定

≥98% (HPLC)

形式

powder

颜色

white to beige

溶解性

DMSO: 15 mg/mL, clear

储存温度

2-8°C

SMILES string

O=C(C)C1=CC(C2=CC=CC=C2OCC3CC3)=C4N=CC=CN41

 

安全信息

储存分类代码

13 - Non Combustible Solids

WGK

WGK 3

商品规格
属性名称属性值
储存温度 Storage temp.2-8°C冷藏
全球实时库存 Availability √美国St. Louis ≥ 20 | 欧洲Eur. ≥ 16 | 東京Tokyo ≥ 5 | 香港与北京 ≥ 20